You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 14, 2024

~ Buy the SODIUM ACETATE ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR SODIUM ACETATE ANHYDROUS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sodium Acetate Anhydrous

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Orphan Europe Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Mayo Clinic Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Acetate Anhydrous

Condition Name

Condition Name for Sodium Acetate Anhydrous
Intervention Trials
Healthy 4
Pachyonychia Congenita 2
Essential Hypertension 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Acetate Anhydrous
Intervention Trials
Nails, Malformed 2
Pachyonychia Congenita 2
Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Acetate Anhydrous

Trials by Country

Trials by Country for Sodium Acetate Anhydrous
Location Trials
United States 27
Canada 3
Spain 3
United Kingdom 2
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Acetate Anhydrous
Location Trials
California 5
Minnesota 4
Utah 2
Florida 2
Connecticut 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Acetate Anhydrous

Clinical Trial Phase

Clinical Trial Phase for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Phase 4 4
Phase 3 3
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Completed 15
Recruiting 4
Not yet recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Acetate Anhydrous

Sponsor Name

Sponsor Name for Sodium Acetate Anhydrous
Sponsor Trials
National Cancer Institute (NCI) 3
MetVital, Inc. 2
Ferring Pharmaceuticals 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Acetate Anhydrous
Sponsor Trials
Other 20
Industry 16
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.